More on pneumonia: Treatment of MRSA in community acquired pneumonia

doi:10.1136/bmj.332.7553.1334

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

James Greig (James.Greig@PHNT.swest.nhs.uk), consultant microbiologist,
Peter Jenks, consultant microbiologist

Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH
Department of Microbiology, Derriford Hospital, Plymouth PL6 8DH

EDITOR—Hoare and Lim's update on the diagnosis and management of community acquired pneumonia does not mention methicillin resistant Staphylococcus aureus (MRSA),1 which is becoming more common in the community as a true community associated organism, in patients in residential care, and in those discharged from hospital. Patients who have newly acquired MRSA often develop further infections unless carriage is cleared. One study showed that in the 18 months after first colonisation, over one quarter of individuals developed further MRSA infections, many of which were …